Disruptions in SIRT1 activity are linked to T2DM and other metabolic dysfunctions; decreased SIRT1 expression and activity have been linked to poor insulin signaling and glucose intolerance [112,113]. The gene discussed is INS; the disease is Glucose intolerance.